Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
postdoctoral experience with single-cell RNA sequencing analysis and expertise in immunology or intestinal biology. This position is within the laboratory of Dr Kylie James at the Garvan Institute
-
contribution of 17% superannuation applies. 24 Months Fixed term Part time position until Oct 2027. This postdoctoral position in computational cognitive science and data science offers an exciting opportunity
-
. The position will provide technical and research knowledge in the field of implementation science, contributing to a range of projects conducted within the Implementation to Impact program, School of Population
-
ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak reactors. We are recruiting
-
coupled nuclear engineering problems, using techniques such as (but not limited to) molecular dynamics, computational fluid dynamics, activation decay codes, kinetic Monte Carlo codes, particle transport
-
combatting wildlife trafficking and environmental harm. To be successful you will need: PhD in a relevant discipline such as computer science, data science, digital forensics, cyber security or a related field
-
Premier’s Science Fellowship Program, the Population Biology and Genomics Group is a new and rapidly growing research group in the School of Molecular and Life Sciences at Curtin University. To find out more
-
PhD in a related area: Mathematics, Computer Science, or Engineering, and have an aptitude and demonstrated capability to publish in top ranked avenues in their field of study. Depending on experience
-
$113,918 to $134,596 pa (ALEV B) Fixed-term (3 years), Full-time, Joondalup campus Open to candidates with the relevant working rights POST DOCTORAL RESEARCH FELLOW SCHOOL OF ENGINEERING JOONDALUP
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural